| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 07/29/2004 | US20040147724 for diagnosis/treatment of cancer, myeloproliferative disorders, angiogenesis, obesity, osteoporosis, non-insulin dependent diabetes, lipid metabolism disorder, hypercalcemia, hypercholestrolemia; genetic engineering |
| 07/29/2004 | US20040146888 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 07/29/2004 | US20040146882 Human acid sensing ion channel 2b (hASIC2b), process for producing the same, and its use |
| 07/29/2004 | US20040146872 Comprises nucleotide sequences coding delta-2-enoyl-coA isomerase for use in identifying modulators for treatment and diagnosis of inflammatory, cardiovascular, skin, body weight and cancer disorders |
| 07/29/2004 | US20040146506 Antibodies specific for a cell surface molecule mediating cell adhesion and signal transmission, cells secreting such antibodies, and methods of making and using such antibodies |
| 07/29/2004 | CA2516027A1 Composter |
| 07/29/2004 | CA2513034A1 Targeted transgenesis using the rosa26 locus |
| 07/28/2004 | EP1441034A1 Methods of evaluating phosphatase inhibitors |
| 07/28/2004 | EP1440164A1 Use of cbg gene as genetic marker of hypercortisolemia and related pathologies |
| 07/28/2004 | EP1439863A2 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 07/28/2004 | EP1439849A2 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease |
| 07/28/2004 | EP1392111A4 Method for targeting transcriptionally active loci |
| 07/28/2004 | CN2627827Y Aphid and mite test clip |
| 07/28/2004 | CN1516734A Transformed silkworm producing human collagen |
| 07/28/2004 | CN1515150A Sex discrimination of mulberry silkworm pod and its silkworm varietly assortive breeding method |
| 07/28/2004 | CN1515145A Greenhouse with ecological agricultural automatic regulation and control function |
| 07/28/2004 | CN1159338C LHRH tandem repeat peptide and vaccine and immunogenic composition |
| 07/27/2004 | US6767719 Mouse telomerase reverse transcriptase |
| 07/27/2004 | US6767712 Models of prion disease |
| 07/27/2004 | CA2279999C The neurotrophic factor nnt-1 |
| 07/22/2004 | WO2004061077A2 Increasing gamete production with a gene switch |
| 07/22/2004 | WO2004060055A1 Wt1 transgenic animal |
| 07/22/2004 | WO2004060053A2 Transgenic mice expressing human cd20 |
| 07/22/2004 | WO2004060052A2 Transgenic mice expressing human cd20 and/or cd16 |
| 07/22/2004 | WO2004032865A9 Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase |
| 07/22/2004 | WO2004028554A3 Skrp, astray, string, vacm associated with metabolic control |
| 07/22/2004 | WO2004027044A3 Triplex hairpin ribozyme |
| 07/22/2004 | WO2004021977A3 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 07/22/2004 | WO2004007547A3 Truncated tau proteins |
| 07/22/2004 | US20040143865 Transgenic fish models for identifying inhibitors of neovascularization; antitumor/antiproliferative agents; wound healing agents |
| 07/22/2004 | US20040143864 Chimeric gene constructs for generation of fluorescent transgenic ornamental fish |
| 07/22/2004 | US20040143863 Expression vectors comprising bone morphogenic protein for use in the transformation of osteoblast and controlling propagation and enrichment of stem cells in vivo |
| 07/22/2004 | US20040143862 Mammalian embryonic stem cell wherein the lecithin:cholesterol acyltransferase-like lysophospholipase gene is inactivated for use as model for identifying modulators for treatment of arteriosclerosis |
| 07/22/2004 | US20040143861 Using satellite artificial chromosome (SATAC) as gene therapeutic tool to transform and propagate transgenic cells and treat metabolic disorders |
| 07/22/2004 | US20040143857 Erythropoietin analog-human serum albumin fusion |
| 07/22/2004 | US20040143855 Using two domain potassium transport protein to identify modulators of wakefulness; drug screening and potassium channel modulators; sleep disorders |
| 07/22/2004 | US20040143854 Using inducible vectors to transform cells and propagate organism for use as drug screening tools; phenotyping |
| 07/22/2004 | US20040143414 Tail suspension test apparatus |
| 07/22/2004 | US20040142468 Modulation of systemic immune responses by transplantation of hematopoietic stem cells transduced with genes encoding antigens and antigen presenting cell regulatory molecules |
| 07/22/2004 | US20040142432 Preparing single chain antibodies comprised of camelid subunits for treating and preventing inflammation, allergies, cancer, infections, transplant rejection, autoimmune and muscular disorders |
| 07/22/2004 | US20040142416 Treatment for phenylketonuria |
| 07/22/2004 | US20040139918 Cricket habitat and retail receptacle |
| 07/22/2004 | CA2507882A1 Transgenic mice expressing human cd20 |
| 07/22/2004 | CA2507880A1 Transgenic mice expressing human cd20 and/or cd16 |
| 07/21/2004 | EP1439234A1 Targeted transgenesis using the rosa26 locus |
| 07/21/2004 | EP1438431A2 Methods for diagnosing and treating heart disease |
| 07/21/2004 | EP1438418A2 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 07/21/2004 | EP1438402A2 Modulators of bone homeostasis identified in a high-throughput screen |
| 07/21/2004 | EP1438401A2 Production of a transgenic avian by cytoplasmic injection |
| 07/21/2004 | EP1438389A2 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer |
| 07/21/2004 | EP1438331A1 A novel modulator of non-genonic activity of nuclear receptors (mnar) and uses thereof |
| 07/21/2004 | EP1438325A2 Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods |
| 07/21/2004 | EP1438075A2 Methods and compositions relating to restricted expression lentiviral vectors and their applications |
| 07/21/2004 | EP1438065A2 An in vivo animal model of chronic arterial occlusion and use of collagenase to facilitate guide wire crossing in chronic arterial occlusions |
| 07/21/2004 | EP0941329B1 Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (lag-3) |
| 07/21/2004 | CN1514003A Construction method using detoxiase gene as stable expression system in silkworm |
| 07/21/2004 | CN1513307A Biological conversion equipment for automatically converting excrement from public lavatory and excrement from farm into animal protein |
| 07/20/2004 | US6764826 Detcting modulators of c-reactive proteins; obtain c-reactive protein, incubate with modulator, monitor binding between reactive protein and modulator |
| 07/20/2004 | US6764679 Preferential protein for use in the diagnosis and treatment of cancers; antitumor agents; anticarcinogeneic agents |
| 07/15/2004 | WO2004058325A2 Ion channels as targets for sleep-related drugs |
| 07/15/2004 | WO2004058042A2 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases |
| 07/15/2004 | WO2004048606A3 Porcine polymorphisms and methods for detecting them |
| 07/15/2004 | WO2004046320A3 METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS |
| 07/15/2004 | WO2004042363A3 In vivo imaging of e2f-regulated bioluminescent proteins |
| 07/15/2004 | WO2004028239A3 Mammal model for autoimmune diseases with dysfunction of socs-1 gene |
| 07/15/2004 | WO2003092715A3 Proteins involved in the regulation of energy homeostasis |
| 07/15/2004 | WO2003044162A3 Genes encoding g-protein coupled receptors and methods of use therefor |
| 07/15/2004 | WO2002066613A3 Novel ecdysone receptor/invertebrate retinoid x receptor-based inducible gene expression system |
| 07/15/2004 | WO2002018619A3 Nucleic acid constructs including a novel t-cell active promoter, and pharmaceutical compositions and methods utilizing same for regulating t-cell mediated immune response |
| 07/15/2004 | US20040139488 Compositions and methods for enhancing disease resistance in fish |
| 07/15/2004 | US20040139487 Transgenic animal and uses thereof |
| 07/15/2004 | US20040139486 Interstitial prostatism model animal |
| 07/15/2004 | US20040139484 Ras p27 animal models and uses thereof |
| 07/15/2004 | US20040137611 Cypridina luciferase fusion for use as diagnostic tool in monitoring synaptic response |
| 07/15/2004 | US20040137573 for drug screening treatments for pain, neuropathy, rheumatoid/osteo arthritis, stroke, inflammation, asthma, allergy, urogenital disorders, incontinence, hypertension, hypotension, perivasular disease; animal models; kits |
| 07/15/2004 | US20040137572 Compositions and methods for generating conditional knockouts |
| 07/15/2004 | US20040137570 Immunoglobulin 2 |
| 07/15/2004 | US20040137450 Als2 gene and amyotrophic lateral sclerosis type 2 |
| 07/15/2004 | US20040137447 Human sphingosine-1-phosphate phosphatase |
| 07/15/2004 | US20040137421 Deposition of the protein in the follicular dendritic cell of a non-human animal and detection by histology, electrophoresis or binding assay |
| 07/15/2004 | US20040137001 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse |
| 07/15/2004 | US20040136966 implantation of hematopoietic stem cells into the myocardium surrounding an infarct following a myocardial infarction, migrate into the damaged area, where they differentiate into myocytes, endothelial cells and smooth muscle cells |
| 07/15/2004 | US20040136960 sphygmomanometer is used to apply pressure to mammalian skin, around a limb, for the purpose of increasing vessel permeability when combined with solution injection into the vessel |
| 07/15/2004 | US20040134440 Compact pedigrees showing heritable traits for many individuals |
| 07/15/2004 | DE10258885A1 Verfahren zur Generierung eines gentechnisch veränderten Organismus Method for generating a genetically modified organism |
| 07/15/2004 | CA2510362A1 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases |
| 07/15/2004 | CA2509528A1 Ion channels as targets for sleep-related drugs |
| 07/14/2004 | EP1437414A2 A method for promoting biocatalyst diversity |
| 07/14/2004 | EP1437413A1 Method of expressing genetically modified protein carrying sugar chain having sialic acid added thereto in insect cells |
| 07/14/2004 | EP1437403A1 Method of screening reporgramming factor, reprogramming factor screened by the method, method of using the reprogramming factor, method of differentiating undifferentiated fused cells and method of constructing cell, tissues and organs |
| 07/14/2004 | EP1437364A2 Polypeptide binding to the androgen receptor and its potential use for treating breast cancer |
| 07/14/2004 | EP1437043A1 Model animal with overexpression of regucalcin |
| 07/14/2004 | EP1437042A1 Hair follicle-reconstitution system and animal carrying the same |
| 07/14/2004 | EP1436393A2 Rapid method of selecting cells for gene disruption by homologous recombination |
| 07/14/2004 | EP1436327A1 Ee3-protein family and corresponding dna sequences |
| 07/14/2004 | EP1436233A2 Metal binding proteins and associated methods |
| 07/14/2004 | EP1436004A1 Crustaceans as production systems for therapeutic proteins |
| 07/14/2004 | EP1435774A1 Enhanced resolution of tumor metastasis |
| 07/14/2004 | EP1017823B1 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 07/14/2004 | EP0754227B1 Chimeric complement inhibitor proteins |